Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project

Journal of Human Hypertension volume 16, pages 597–604 (2002)Cite this article

Abstract

Pharmacological and clinical studies on the effects of angiotensin-converting enzyme (ACE) inhibitors support the idea of a central role played Angiotensin II which is able to cause cardiovascular and renal diseases also independently of its blood pressure elevating effects. The present investigation was aimed at evaluating the effect(s) of three different pharmacological regimens on both blood pressure and sympathetic drive in uncomplicated essential hypertension, by means of blood pressure laboratory measurements and ambulatory monitoring, 24-h heart rate variability and plasma noradrenaline levels. Thus, an ACE-inhibitor monotherapy (trandolapril, 2 mg/day), an AT1-receptor antagonist monotherapy (irbesartan, 300 mg/day), their low-dose combination (0.5 mg/day plus 150 mg/day, respectively) and placebo were given, in a randomised, single-blind, crossover fashion for a period of 3 weeks each to 12 mild essential hypertensives. Power spectral analysis (short recordings) and noradrenaline measurements were also performed in the supine position and after a postural challenge (60° head-up tilting test: HUT). The low-dose combination therapy induced the greatest reduction in LF component and in LF/HF ratio, both in the resting and tilted positions, as well as in blood pressure. However, the physiological autonomic response to HUT was maintained. Noradrenaline plasma levels were lower after the combined therapy than after each drug alone. Our data demonstrate that in mild and uncomplicated essential hypertension, the chronic low-dose combination therapy with an ACE-inhibitor and an AT1-antagonist is more effective than the recommended full-dose monotherapy with either drug in influencing the autonomic regulation of the heart, suggesting a relative reduction in sympathetic drive both at cardiac and systemic levels.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Timmemans PBMWM et al. Angiotensin II receptors and angiotensin II receptor antagonists Pharmacol Rev 1993; 45: 205–251

    Google Scholar 

  2. Kim S, Iwao H . Molecular and cellular mechanisms of angiotensin II mediated cardiovascular and renal disease Pharmacol Rev 2000; 52: 11–34

    CAS  PubMed  Google Scholar 

  3. Weir MR, Dzau VJ . The renin-angiotensin-aldosterone system: a specific target for hypertension management Am J Hypertens 1999; 12: 205S–213S

    Article  CAS  PubMed  Google Scholar 

  4. Zimmerman BG . Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci 1981; 60: 343–348

    Article  CAS  Google Scholar 

  5. Rump LC et al. Beta2 adrenergic receptor and angiotensin II receptor modulation of sympathetic neurotransmission in human atria Circ Res 1994; 74: 434–440

    Article  CAS  PubMed  Google Scholar 

  6. Horackova M, Armour JA . ANG II modifies cardiomyocyte functions via extracardiac and intracardiac neurons. In situ and in vitro studies Am J Physiol 1997; 272: R766–R775

    CAS  PubMed  Google Scholar 

  7. Henegar JR, Schwartz DD, Janicki JS . Ang II-related myocardial damage: role of cardiac sympatheticcatecholamines and beta-receptor regulation Am JPhysiol 1998; 275: H534–H541

    CAS  Google Scholar 

  8. Rump LC et al. Angiotensin converting enzyme inhibition unmasks the sympathofacilitatory effect ofbradykinin in human right atrium J Hypertens 1997; 15: 1263–1270

    Article  CAS  PubMed  Google Scholar 

  9. Dendorfer A, Raasch W, Tempel K, Dominiak P . Interactions between the renin-angiotensin system (RAS) and the sympathetic system Basic Res Cardiol 1998; 93 (Suppl 2): 24–29

    Article  CAS  PubMed  Google Scholar 

  10. Rongen AG et al. Neural and hypotensive effects of angiotensin II receptor blockade Hypertension 1998; 31: 378–383

    Article  CAS  PubMed  Google Scholar 

  11. de Champlain J et al. Effects of trandolapril on the sympathetic tone and reactivity in systemic hypertension Am J Cardiol 1994; 73: 18–25

    Article  Google Scholar 

  12. Giattanasio C et al. Sympatho-moderating influence of benzepril in essential hypertension J Hypertens 1992; 10: 373–378

    Article  Google Scholar 

  13. Work RH, Ibsen H, Frandsenn E, Dige-Peterson H . AT1 receptor blockade and the sympathoadrenal response to insulin-induced hypoglycemia in humans Am J Physiol 1997; 272: E415–421

    Google Scholar 

  14. Weber MA . Interrupting the renin-angiotensin system. The role of angiotensin-converting enzyme and angiotensin II receptor antagonists in the treatment of hypertension Am J Hypertens 1999; 12: 189–194S

    Article  Google Scholar 

  15. Joint National Commitee on prevention, detection, evaluation, and treatment of high blood pressure. the sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure Arch Intern Med 1997; 157: 2413–2446

  16. Devereux RB et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings Am J Cardiol 1986; 57: 450–458

    Article  CAS  PubMed  Google Scholar 

  17. De Simone G et al. Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight J Am Coll Cardiol 1992; 20: 1251–1260

    Article  CAS  PubMed  Google Scholar 

  18. Lazzeri C, Barletta G, La Villa G, Franchi F . 24-hour heart rate variability inpatients with vaso-vagal syncope PACE 2000; 23: 463–468

    Article  CAS  PubMed  Google Scholar 

  19. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation and clinical use Circulation 1996; 93: 1043–1065

  20. Baselli G et al. Heart rate variability signal processing: a quantitative approach as an aid to diagnosis in cardiovascular pathologies Int J Biomed Computing 1987; 20: 51–70

    Article  CAS  Google Scholar 

  21. Malliani A et al. Individual recognition by heart rate variability of two different autonomic profiles related to posture Circulation 1997; 96: 4143–4145

    Article  CAS  PubMed  Google Scholar 

  22. Lazzeri C et al. Effects of acute clonidine administration on power analysis of heart rate variability in healthy humans J Autonom Pharmacol 1998; 18: 307–312

    Article  CAS  Google Scholar 

  23. Malliani A, Pagani M, Lombardi F, Cerutti S . Cardiovascular neural regulation explored in the frequency domain Circulation 1991; 84: 482–491

    Article  CAS  PubMed  Google Scholar 

  24. Franchi F et al. Centrally mediated effects of bromocriptine on cardiac sympatho-vagal balance Hypertension 2001; 38: 123–129

    Article  CAS  PubMed  Google Scholar 

  25. Mannelli M et al. In vivo evidence that endogenous dopamine modulates sympathetic activity in man Hypertension 1999; 34: 398–402

    Article  CAS  PubMed  Google Scholar 

  26. Neri Serneri GG et al. Prostacyclin and thromboxane A2 formation in response to adrenergic stimulation in humans: a mechanism for local control of vascular response to sympathetic activation? Cardiovasc Res 1981; 15: 287–295

    Article  CAS  Google Scholar 

  27. Pancera P et al. Effect of losartan on heart rate and blood pressure variability during tilt test and trinitroglycerine vasodilation J Hypertens 1999; 17: 513–521

    Article  CAS  PubMed  Google Scholar 

  28. Vaile JC et al. Effects of angiotens II receptor blockade on cardiac vagal control in heart failure Clin Sci 2001; 101: 559–566

    Article  CAS  Google Scholar 

  29. Hamroff G et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity inpatients with severe congestive heart failure Circulation 1999; 99: 990–992

    Article  CAS  PubMed  Google Scholar 

  30. Mckelvie RS et al. Comparison of candesartan, enalapril and their combination in congestive heart failure: Randomized Evaluation of Strategies for Left Ventricular Dysfunction (RESOLVD) pilot study. The RESOLVD Pilot Study Investigators Circulation 1999; 100: 1056–1064

    Article  CAS  PubMed  Google Scholar 

  31. Burnier M, Brunner HR . Angiotensin II receptor antagonists Lancet 2000; 355: 637–644

    Article  CAS  PubMed  Google Scholar 

  32. Marino MR, Langenbacher K, Ford NF, Uderman HD . Pharmacokinetics and pharmacodynamics of irbesartan in healthy subjects J Clin Pharmacol 1998; 38: 246–255

    Article  CAS  PubMed  Google Scholar 

  33. Kingwell BA et al. Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure Circulation 1994; 90: 234–240

    Article  CAS  PubMed  Google Scholar 

  34. Cleamson B et al. Prejunctional angiotensin II receptors. Facilitation of norepinephrine in the human forearm J Clin Invest 1994; 93: 684–691

    Article  Google Scholar 

  35. Raasch W et al. Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats J Hypertens 2001; 19: 1827–1833

    Article  CAS  PubMed  Google Scholar 

  36. MacMahon S et al. Blood pressure, stroke and coronary heart disease. I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression diluition bias Lancet 1990; 335: 765–774

    Article  CAS  PubMed  Google Scholar 

  37. Brooks DR, Julius S . Autonomic imbalance, hypertension and cardiovascular risk Am J Hypertens 2000; 13: 112S–122S

    Article  Google Scholar 

  38. Esler M . The sympathetic system in hypertension Am J Hypertens 2000; 13: 99S–105S

    Article  CAS  PubMed  Google Scholar 

  39. Dzau VJ . Cardiac renin angiotensin system. Molecular and functional aspect Am J Med 1988; 84: 22–27

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, University of Florence, School of Medicine, Florence, Italy

    F Franchi, C Lazzeri, M Foschi & C Tosti-Guerra

  2. Section of Cardiovascular Ultrasound, Azienda Ospedaliera Careggi, Florence, Italy

    G Barletta

Authors
  1. F Franchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Lazzeri
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Foschi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Tosti-Guerra
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. G Barletta
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to F Franchi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Franchi, F., Lazzeri, C., Foschi, M. et al. Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project. J Hum Hypertens 16, 597–604 (2002). https://doi.org/10.1038/sj.jhh.1001453

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jhh.1001453

Keywords

Search

Advanced search

Quick links